ENSC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ensysce Biosciences Inc (ENSC) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is significantly declining, there are no positive catalysts or trading signals, and the technical indicators are neutral. Additionally, there is no recent news or influential trading activity to suggest an imminent turnaround.
The MACD is slightly positive but contracting, RSI is neutral at 52.195, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 0.527, with resistance at 0.624 and support at 0.43.
NULL identified. No recent news or significant insider or hedge fund activity.
is down 1.79%, which reflects negative sentiment.
In Q3 2025, revenue dropped to $493,104 (-85.58% YoY), net income dropped to -$3,729,128 (-663.51% YoY), and EPS dropped to -1.29 (-229.00% YoY). Gross margin remained flat at 100%.
No analyst ratings or price target changes available.
